Jae Joon Kim

Mr. Jae Joon Kim joined ImunoMet’s Board of Directors in March 2016. Mr. Kim is currently a Director of the Venture Investment Division of Korea-based Mirae Asset Venture Investments (Mirae Asset). Since 2009, he has been leading the Venture Investment Division of Mirae Asset and has successfully listed over 15 companies on the NASDAQ, KOSDAQ and KONEX stock market exchanges. He currently manages an equity investment portfolio comprised of more than 30 biopharmaceutical and medical diagnostics companies worldwide. Mr. Kim has held several positions since joining Mirae Asset in 2006, including the Team Head of the Venture Investment Division and the Team Head of the Corporate Strategic Division. Prior to joining Mirae Asset, from 2002 to 2006, Mr. Kim was a research associate at Macrogen, a Korea-based biotech company. Mr. Kim earned a Master’s Degree from the Graduate School of Medicine, Korea University and a Bachelor of Science degree from Korea University.